Difference between revisions of "Sanofi"
Josh Leeson (talk | contribs) |
Josh Leeson (talk | contribs) |
||
| Line 15: | Line 15: | ||
==Lobbying firms== | ==Lobbying firms== | ||
*[[Portland PR]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Portland Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref> | *[[Portland PR]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Portland Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref> | ||
| + | *[[JMC Partners LLP]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=JMC%20Partners%20LLP Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref> | ||
==Notes== | ==Notes== | ||
Revision as of 14:42, 29 January 2015
Sanofi is a global healthcare leader focused on patients’ needs. They engage in the research, development, manufacturing and marketing of 'innovative therapeutic solutions'. [1]
Sanofi has core strengths in healthcare, with 7 growth platforms
- diabetes solutions
- human vaccines
- innovative drugs
- consumer healthcare
- emerging markets
- animal health
- the new Genzyme. [1]
Affiliations
Sanofi is currently a donor to the Science Media Centre according to the SMC.
Lobbying firms
Notes
- ↑ 1.0 1.1 Our Company Sanofi, accessed 7 November 2014
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
